Atea Pharmaceuticals [AVIR] vs Third Harmonic Bio [THRD] Detailed Stock Comparison

Atea Pharmaceuticals

NASDAQ

Third Harmonic Bio

NASDAQ

TLDR: Quick Comparison Summary

Based on 15 vital metrics comparison: Atea Pharmaceuticals wins in 5 metrics, Third Harmonic Bio wins in 7 metrics, with 2 ties. Third Harmonic Bio appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Atea Pharmaceuticals	Third Harmonic Bio	Better
P/E Ratio (TTM)	-1.70	12.46	Atea Pharmaceuticals
Price-to-Book Ratio	0.75	0.89	Atea Pharmaceuticals
Debt-to-Equity Ratio	0.34	1.10	Atea Pharmaceuticals
PEG Ratio	0.20	0.17	Third Harmonic Bio
EV/EBITDA	0.77	0.40	Third Harmonic Bio
Profit Margin (TTM)	0.00%	0.00%	Tie
Operating Margin (TTM)	0.00%	0.00%	Tie
Return on Equity	-32.38%	-19.94%	Third Harmonic Bio
Return on Assets (TTM)	-20.16%	-14.60%	Third Harmonic Bio
Free Cash Flow (TTM)	$-135.50M	$-34.51M	Third Harmonic Bio
1-Year Return	-7.50%	-53.82%	Atea Pharmaceuticals
Enterprise Value	$-111.83M	$-25.82M	Third Harmonic Bio
Revenue per Share (TTM)	$0	N/A	N/A
Earnings per Share (Diluted)	$-1.62	$-1.24	Third Harmonic Bio
Beta (Stock Volatility)	0.25	2.13	Atea Pharmaceuticals

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Atea Pharmaceuticals vs Third Harmonic Bio Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Atea Pharmaceuticals	-3.76%	-4.03%	-5.67%	3.10%	14.83%	-2.63%
Third Harmonic Bio	0.00%	0.00%	-1.28%	4.47%	56.85%	-51.27%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Atea Pharmaceuticals	-7.50%	-57.74%	-89.02%	-89.02%	-89.02%	-89.02%
Third Harmonic Bio	-53.82%	-70.11%	-70.11%	-70.11%	-70.11%	-70.11%

Performance & Financial Health Analysis: Atea Pharmaceuticals vs Third Harmonic Bio

Metric	AVIR	THRD
Market Information
Market Cap i	$244.94M	$242.79M
Market Cap Category	Micro cap	Micro cap
10 Day Avg. Volume i	349,460	173,590
90 Day Avg. Volume i	357,100	175,425
Last Close	$3.33	$5.38
52 Week Range	$2.45 - $4.14	$3.18 - $16.02
% from 52W High	-19.66%	-66.42%
All-Time High	$94.17 (Feb 08, 2021)	$24.59 (Oct 31, 2022)
% from All-Time High	-96.46%	-78.12%
Growth Metrics
Quarterly Revenue Growth	N/A	N/A
Quarterly Earnings Growth	N/A	N/A
Financial Health
Profit Margin (TTM) i	0.00%	0.00%
Operating Margin (TTM) i	0.00%	0.00%
Return on Equity (TTM) i	-0.32%	-0.20%
Debt to Equity (MRQ) i	0.34	1.10
Cash & Liquidity
Book Value per Share (MRQ)	$4.49	$6.06
Cash per Share (MRQ)	$4.79	$6.02
Operating Cash Flow (TTM) i	$-116,865,000	$-41,687,000
Levered Free Cash Flow (TTM) i	$-60,696,376	$-28,660,250
Dividends
Last 12-Month Dividend Yield i	N/A	N/A
Last 12-Month Dividend i	N/A	N/A

Valuation & Enterprise Metrics Analysis: Atea Pharmaceuticals vs Third Harmonic Bio

Metric	AVIR	THRD
Price Ratios
P/E Ratio (TTM) i	-1.70	12.46
Forward P/E i	-2.20	-3.49
PEG Ratio i	0.20	0.17
Price to Sales (TTM) i	N/A	N/A
Price to Book (MRQ) i	0.75	0.89
Market Capitalization
Market Capitalization i	$244.94M	$242.79M
Enterprise Value i	$-111,825,624	$-25,821,452
Enterprise Value Metrics
Enterprise to Revenue i	N/A	N/A
Enterprise to EBITDA i	0.77	0.40
Risk & Other Metrics
Beta i	0.25	2.13
Book Value per Share (MRQ) i	$4.49	$6.06

Financial Statements Comparison: Atea Pharmaceuticals vs Third Harmonic Bio

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	AVIR	THRD
Revenue/Sales i	$0	$0
Cost of Goods Sold i	N/A	N/A
Gross Profit i	N/A	N/A
Research & Development i	$32.28M	$10.65M
Operating Income (EBIT) i	$-41.35M	$-18.72M
EBITDA i	$-41.24M	$-18.70M
Pre-Tax Income i	$-36.95M	$-15.83M
Income Tax i	$207,000	N/A
Net Income (Profit) i	$-37.16M	$-15.83M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	AVIR	THRD
Cash & Equivalents i	$119.39M	$271.61M
Total Current Assets i	$433.71M	$276.00M
Total Current Liabilities i	$21.75M	$5.10M
Long-Term Debt i	$634,000	$2.11M
Total Shareholders Equity i	$411.08M	$272.62M
Retained Earnings i	$-398.49M	$-175.52M
Property, Plant & Equipment i	$1.86M	$2.85M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	AVIR	THRD
Operating Cash Flow i	$-28.53M	$-11.78M
Capital Expenditures i	N/A	$0
Free Cash Flow i	$-30.56M	$-13.48M
Debt Repayment i	N/A	N/A
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	AVIR	THRD
Shares Short i	4.89M	1.42M
Short Ratio i	12.97	6.95
Short % of Float i	0.08%	0.05%
Average Daily Volume (10 Day) i	349,460	173,590
Average Daily Volume (90 Day) i	357,100	175,425
Shares Outstanding i	84.46M	44.86M
Float Shares i	60.01M	15.60M
% Held by Insiders i	0.13%	0.09%
% Held by Institutions i	0.72%	0.80%

Dividend Analysis & Yield Comparison: Atea Pharmaceuticals vs Third Harmonic Bio

Metric	AVIR	THRD
Last 12-Month Dividend i	N/A	N/A
Last 12-Month Dividend Yield i	N/A	N/A
3-Year Avg Annual Dividend i	N/A	N/A
3-Year Avg Dividend Yield i	N/A	N/A
3-Year Total Dividends i	N/A	N/A
Ex-Dividend Date	N/A	N/A